Patents for A61L 33 - Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment (5,725)
06/2001
06/07/2001WO2001039813A1 Electropolymerizable monomers and polymeric coatings on implantable devices
06/07/2001US20010003126 Composition of first synthetic polymer having nucleophilic groups and second polymer having electrophilic groups capable of reacting to form covalent bonds with the first polymer; formation of a synthetic lenticule
05/2001
05/31/2001WO2001037893A1 Method of covalent coupling
05/31/2001WO2001037719A2 Prognostic testing of organs intended for transplantation
05/31/2001US20010002435 Medical device for delivering a therapeutic substance and method therefor
05/31/2001CA2390599A1 Prognostic testing of organs intended for transplantation
05/29/2001US6238795 Divinylbenzene-styrene resin bonded through the vinyl moieties to hemocompatible polymeric surface coating material; absorption of microglobulins from blood
05/25/2001WO2001036613A1 Blood-compatible polymer surfaces
05/22/2001US6235778 Anticoagulants
05/22/2001US6235340 Nonstick surfaces for resistant to adhesion of biopolymers
05/16/2001EP1098670A1 Crosslinking of bioprosthetic material to mitigate post-implantation calcification
05/16/2001EP0927222B1 Thermoplastic polyurethanes containing active substances
05/15/2001US6232434 Polymers for delivering nitric oxide in vivo
05/10/2001US20010001038 A free-flowing suspension of activated carbon particles ground and graded to <50 mu; antiagglomerants; grinding in a cylindrical rod mill in a chamber coated with a nonabrasive lining; accuracy
05/10/2001DE19950386A1 Biokompatibler Gegenstand Biocompatible article
05/03/2001WO2001030403A1 Biocompatible medical devices
05/03/2001US20010000785 Attaching a bioeffecting agent to a substrate with an anchor provided by a linker compound which also forms a cleavable linkage so that the drug has a sustained release; anti-thrombogenic, -imicrobial, -inflammatory agents
05/03/2001CA2388976A1 Medical devices rendered more pharmaceutically compatible via polymeric or surface treatment
05/02/2001EP1094849A1 Methods for increasing vascularization and promoting wound healing
05/01/2001US6224626 Ultra-thin expandable stent
04/2001
04/26/2001WO2001028605A1 Biocompatible coated implant
04/26/2001WO2000050106A3 Hemocompatible surfaces and method for producing same
04/26/2001CA2388153A1 Biocompatible article
04/25/2001EP1093468A1 Polymers for delivering nitric oxide in vivo
04/25/2001CN1292668A Expandable stent
04/19/2001WO2001027209A1 Zwitterionic polymer blend materials
04/19/2001WO2000048645A3 Apparatus and method for selectively delivering medication to a wall section of a body cavity, blood vessel, or the like
04/12/2001WO2001024866A1 System and device for preventing restenosis in body vessels
04/12/2001CA2386007A1 System and device for preventing restenosis in body vessels
04/11/2001CN1064265C Anticoagulation composite and its preparing method
04/10/2001US6214054 Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
04/05/2001WO2001023016A1 Intraluminal device, coating for such device, and method for preparing said device
04/04/2001EP1088564A1 Intraluminal device, coating for such device, as well as a method for preparing the intraluminal device
04/04/2001EP1087799A1 Method for producing biocompatible surfaces
03/2001
03/29/2001WO2001021326A1 Water-soluble coating agents bearing initiator groups and coating process
03/29/2001WO2001021228A1 Cardiac valve and method for preparing a biological tissue
03/28/2001EP1086149A1 Surfactants that mimic the glycocalyx
03/28/2001EP1085918A1 Biocompatible crack-resistant coating compositions
03/28/2001EP0779815B1 Surface-modifying copolymers having cell adhesion properties
03/27/2001US6207749 Comb copolymers for regulating cell-surface interactions
03/27/2001CA2153466C Medical instruments that exhibit surface lubricity when wetted
03/21/2001EP1083946A1 Stents with a diamond like coating
03/20/2001US6204254 Biocompatible surfaces and a method for their preparation
03/20/2001US6203536 Medical device for delivering a therapeutic substance and method therefor
03/15/2001WO2001017578A1 New biocompatible polymer systems carrying triflusal or htb
03/15/2001WO2001017577A1 A porous prosthesis and a method of depositing substances into the pores
03/15/2001WO2001017575A1 Graft polymerization of substrate surfaces
03/15/2001CA2383780A1 New biocompatible polymeric systems carrying triflusal or htb
03/14/2001CN1287498A Biocompatible polymer film
03/13/2001US6200588 Blood-compatible composition and medical device using same
03/08/2001WO2001015764A1 Coating having biological activity and medical implant having surface carrying the same and method
03/08/2001WO2001015751A1 Novel multilayered material bearing a biologically active agent and the preparation thereof
03/08/2001WO2001015734A2 High viscosity liquid controlled delivery system and medical or surgical device
03/08/2001WO2001015631A1 Method for producing improved medical devices and devices so produced
03/08/2001CA2383472A1 Novel multilayered material bearing a biologically active agent and the preparation thereof
03/06/2001US6197051 Medical device with a biocompatible coating formed form a polycarbonate-polyurethane polymer, having thereon emulfifying agents which include one or more organic acid functional groups; can be applied at low temperature
02/2001
02/28/2001EP1077654A1 Intra vascular implant and method of manufacture thereof
02/27/2001US6193752 Urological implant, in particular vascular wall support for the urinary tract
02/22/2001WO2001012675A1 Glycosaminoglycan derivatives and utilization thereof
02/22/2001WO2001012203A1 Method of preventing adhesions with absorbable polyoxaesters
02/22/2001CA2380928A1 Method of preventing adhesion with absorbable polyoxaesters
02/20/2001CA2028069C Anti-thrombogenic, and/or anti-microbial composition
02/15/2001WO2001010342A1 Thrombosis filter having a surface treatment
02/13/2001US6187038 Small bore biologic graft with therapeutic delivery system
02/08/2001WO2001008718A1 Universal biocompatible coating platform for medical devices
02/08/2001WO2001008570A1 A cutting blade for a surgical instrument
02/08/2001DE19937219A1 Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Ionenaustauscherchromatographie A process for the purification of the blood clotting factor VII-activating protease, its pro-enzyme or a mixture of both proteins by ion-exchange chromatography
02/08/2001DE19937218A1 Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie A process for the purification of the blood clotting factor VII-activating protease, its pro-enzyme or a mixture of both proteins by affinity chromatography
02/07/2001EP1074616A1 Process for purification of the factor VII-activating protease, its proenzyme or a mixture of both proteins, by ion-exchange chromatography
02/07/2001EP1074615A1 Methods for purification of Factor VII activating Protease, its proenzyme or a mixture of both forms, by affinity chromatography
02/07/2001EP1073449A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
02/06/2001CA2315309A1 Process for the preparation in pure form of the protease activating blood clotting factor vii, its proenzyme or a mixture of both proteins by means of affinity chromatography
02/06/2001CA2315306A1 Process for the preparation in pure form of the protease activating blood clotting factor vii, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography
02/01/2001WO2001007097A1 Medical materials and process for producing the same
01/2001
01/31/2001EP1071467A1 Comb copolymers for regulating cell-surface interactions
01/30/2001CA2011171C Biodegradable poly (phosphate esters)
01/24/2001EP1070049A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
01/24/2001EP1069916A2 Latent reactive blood compatible agents
01/24/2001EP1069870A1 Small bore biologic graft with therapeutic delivery system
01/23/2001US6177609 Biocompatible aqueous slurry for forming fluid-tight barrier on surface of porous implantable prosthesis; a cryogenically milled protein comminutate of uniform particle size; highly controlled viscosity and solubility; protective coatings
01/23/2001US6177013 Use of a neutral or cationic polymer to prevent to activation of blood or plasma in contact with a semi-permeable membrane
01/23/2001US6176849 Hydrophilic lubricity coating for medical devices comprising a hydrophobic top coat
01/17/2001EP1067972A1 Multicomponent complex for use with a substrate
01/16/2001US6174934 Artificial prostheses for biomedical use, such as orthopedic applications; oxidation resistance
01/16/2001US6174539 Localized use of nitric oxide adducts to prevent internal tissue damage
01/16/2001US6174326 A stainless steel stent has an anticoagulant covalently bonded on its surface, and anticoagulant is immobilized onto the stent surface through coupling agent having two or more amino group and a crosslinker having two aldehyde or epoxy groups
01/16/2001CA2277953C Polymeric surface coatings
01/10/2001EP1035855A4 Process for the surface modification of a polymer substrate and polymers formed therefrom
01/09/2001US6171343 Ultra high molecular weight polyethylene components treated to resist shearing and frictional wear
01/09/2001US6171298 Intravesical infuser
01/09/2001US6171232 Method for targeting in vivo nitric oxide release
01/03/2001EP1064292A1 Photoactivatable nucleic acid derivatives
01/03/2001EP1064034A1 Vascular graft with improved surface flow
01/02/2001CA2112411C Polymeric surface coatings
12/2000
12/26/2000US6166130 Providing synthetic polymer containing nucleophilic groups and second polymer containing electrophilic groups; contacting polymers to initiate crosslinking; simultaneously applying to tissue surface; crosslinking to form three-dimensional matrix
12/21/2000WO2000076533A1 Hemoactive compositions and methods for their manufacture and use
12/20/2000EP1060750A2 Method for treating amyloidosis
12/20/2000EP1060747A2 Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase
12/20/2000EP1060204A1 Sulphated hyaluronic acid and sulphated derivatives thereof covalently bound to polyurethanes, and the process for their preparation
12/20/2000EP1060031A1 Medical article with coated surfaces exhibiting low friction and low protein adsorption
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 58